Top Medical Searches

Tekmira and Collaborators Demonstrate Efficacy of RNAi Against Hepatitis C Virus

Vancouver, BC — Tekmira Pharmaceuticals Corporation(Nasdaq: TKMR, TSX: TKM), a leading developer of RNA interference(RNAi) therapeutics, announced today a presentation of datademonstrating, for the first time, in vivo efficacy of RNAi…


 Read more…

Be Sociable, Share!
September 14th, 2011 Posted in Drug
Copyright 2008 © Drugs and Diseases. Developed by Axilosoft
Home | About Us | Privacy Policy | Contact Us